FRR Shares (Makes you Realise)

Equity

Home/ Are You A Trader/ Market Info/ Company Profile/ Smart Quotes

COMPANY PROFILE

AMRUTANJAN HEALTH CARE LTD.

NSE : AMRUTANJANBSE : 590006ISIN CODE : INE098F01031Industry : Pharmaceuticals & DrugsHouse : Amrutanjan

BSE765.85-3.45 (-0.45 %)

PREV CLOSE (Rs.) 769.30

OPEN PRICE (Rs.) 769.35

BID PRICE (QTY) 765.00 (2)

OFFER PRICE (QTY) 0.00 (0)

VOLUME 5584

TODAY'S LOW / HIGH (Rs.)758.60 789.95

52 WK LOW / HIGH (Rs.)548.05 835.45

NSE763.90-4.45 (-0.58 %)

PREV CLOSE( Rs. ) 768.35

OPEN PRICE (Rs.) 772.15

BID PRICE (QTY) 763.90 (10)

OFFER PRICE (QTY) 0.00 (0)

VOLUME 43689

TODAY'S LOW / HIGH(Rs.) 758.00 790.95

52 WK LOW / HIGH (Rs.)544.1 842.9

More From Company Profile

Smart Quotes

BSE NSE

1D 1M 3M 1Y 3Y 5Y

STOCK SUMMARY

Trade Value (Rs. in Lacs)

42.77

Dividend Yield(%)

0.60

TTM EPS (Rs.)

18.86

P/E Ratio

40.60

Book Value (Rs.)

115.70

Face Value (Rs.)

MCap (Rs. in Mn)

22141.21

Price/Earning (TTM)

36.30

Price/Sales (TTM)

4.79

Price/Book (MRQ)

6.62

PAT Margin (%)

11.25

ROCE (%)

22.58

Incorporation Year : 09-09 1936

Management Info :

S Sambhu Prasad - Chairman S Sambhu Prasad - Managing Director

Registered Office :

Address : New 103 (Old 42-45),Luz Church Road,Mylapore,
Chennai,
Tamil Nadu-600004

Phone : 044-24994164 / 24994146 / 24994465 / 24994366 / 24669000

Email : customercare@amrutanjan.com

Website : www.amrutanjan.com

Registrars Details :

Cameo Corporate Services Ltd

Subramanian Buildings No 1 ,Club House Road,,Chennai

Listing : BSE, NSE

NEWS

07Jul Amrutanjan Health Care informs about R
Amrutanjan Health Care has informed that it enclosed the certificate iss..

07Apr Amrutanjan Health Care informs about c
Pursuant to Regulation 74 (5) of the SEBI (Depository Participants) Regu..

17Jul Amrutanjan Health Care informs about l
Amrutanjan Health Care has informed that the Company has received a requ..

Financials

	QTR Jun 25	ANNUAL 25
Net Profit	83.1000000000001	508.36
Gross Profit	112.92	691.35
Operating Profit	128.75	758.8
Net Sales	940.46	4518.16

Rs. in Millions

ROLLING FORWARD P/E (EOD)

EVENT CALENDAR

peer group

Cohance Lifesciences (BSE)

1011.20 (9.54%)

M.Cap (Rs. in Cr)38685.19

Procter&Gamble Healt (BSE)

6525.95 (0.94%)

M.Cap (Rs. in Cr)10832.67

Haleos Labs (BSE)

1169.00 (4.52%)

M.Cap (Rs. in Cr)353.42

Glaxosmithkline Phar (BSE)

2811.40 (1.48%)

M.Cap (Rs. in Cr)47626.81

Shareholding Pattern

	PROMOTERS	46.52%
	NON-INSTITUTION	38.37%
	MUTUAL FUNDS/UTI	7.55%
	FI/BANKS/INSURANCE	0.09%
	GOVERNMENT	0%
	FII	0%

Mf Holding

Scheme Name

Hold(%)

ICICI Pru FMCG Fund(G)

2.51

DSP Small Cap Fund-Reg(G)

0.62

Attention Investors

Stock Brokers can accept securities as margin from clients only by way of pledge in the depository system w.e.f. September 1, 2020. Update your mobile number & email Id with your stock broker/depository participant and receive OTP directly from depository on your email id and/or mobile number to create pledge. Check your securities / MF / bonds in the consolidated account statement issued by NSDL/CDSL every month, Issued in the interest of Investors.

Risk Disclosure on Derivatives | Smart ODR | Mandatory Display | KYC Validation Links

BSE / NSE SEBI Registration No. INZ000279232, Depository Participant SEBI Registration No. – IN DP CDSL 132-2015

Mutual funds - ARN No. 81648 , Investment Adviser SEBI Registration No. : INA000008668.

close X

Download Client Registration Documents

Download Client Registration Documents (Rights & Obligations, Risk Disclosure Document, Do's & Don't's) in Vernacular Language :

Assamese Bengali Gujarati Hindi Kanada

Kashmiri Konkani Malyalam Marathi Oriya

Punjabi Sindhi Tamil Telegu Urdu

NOTE : " This document is a translated version of the client registration documents in English and is being provided in vernacular language to facilitate better understanding by the investors. In case of any ambiguity, the contents of the English version would prevail. "

CLOSE X

Risk Disclosures On Derivatives

9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
On an average, loss makers registered net trading loss close to ₹ 50,000.
Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.

Source:

1. SEBI study dated January 25, 2023 on “Analysis of Profit and Loss of Individual Traders dealing in equity Futures and Options (F&O) segment”, wherein Aggregate Level findings are based on annual Profit/Loss incurred by individual traders in equity F&O during FY 2021-22